Assessing "First Mile" Supply Chain Factors Affecting Timeliness of School-Based Deworming Interventions: Supply and

Kimberly M Koporc1, Eric Strunz1, Cassandra Holloway1

  • 1Children Without Worms, Task Force for Global Health, Decatur, Georgia, United States of America.

Insights

Children Without Worms (CWW) evaluated drug donation programs for soil-transmitted helminthiasis (STH) control. Most mass drug administrations (MDAs) were on time, but supply chain issues caused delays or missed treatments, impacting coverage.

Area of Science:

  • Global Health
  • Infectious Disease Epidemiology
  • Pharmaceutical Supply Chain Management

Background:

  • Children Without Worms (CWW) managed Johnson & Johnson's mebendazole donations for school-aged children to combat soil-transmitted helminthiasis (STH) from 2007-2012.
  • The study reviewed program data from 14 STH-endemic countries to identify factors influencing mass drug administration (MDA) timeliness and supply chain performance in drug donation programs.

Purpose of the Study:

  • To identify factors associated with on-time, delayed, or missed mass drug administration (MDA) interventions.
  • To explore potential indicators for evaluating supply chain performance in drug donation programs for neglected tropical diseases (NTDs).

Main Methods:

  • Program data, including drug applications, shipping records, and annual treatment reports, were tracked using Microsoft Excel.
  • Qualitative data from key personnel interviews provided context for delays or missed MDAs.
  • Four potential factors were examined: production, shipping, customs clearance, and in-country issues. Coverage rates were calculated based on targeted vs. administered treatments.

Main Results:

  • Out of 78 approved requests, 54 MDAs (69%) were implemented on time or early.
  • 13% of MDAs were delayed, with most by one month or less.
  • 18% of MDAs were missed, and the mean coverage for on-time or delayed MDAs was approximately 88%.

Conclusions:

  • Four key performance indicators for supply chain management in NTD drug donation programs were identified.
  • These indicators include donor inventory availability, timely shipment of requested doses, timely arrival at central medical stores, and scheduled MDA implementation by country programs.
  • These metrics can help assess and improve supply chain processes for future drug donation initiatives.
Abstract

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
45
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
373
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
44
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
417
Factors Influencing Drug Absorption: Anatomical Parameters01:23

Factors Influencing Drug Absorption: Anatomical Parameters

Drug absorption involves the movement of drugs from the point of administration into the systemic circulation. Initially, Gastrointestinal (GI) motility propels the drug through the digestive tract and into the stomach. However, the stomach's high acidity and limited surface area restrict its role in drug absorption for most drugs. The drug then moves from the stomach to the small intestine via gastric emptying, which can be slowed by various factors, including interactions with other...
850
Modified-Release Drug Delivery Systems: Influencing Factors01:20

Modified-Release Drug Delivery Systems: Influencing Factors

Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
128